Rituximab in rheumatoid arthritis: A double-blind, placebo-controlled, dose-ranging trial.

被引：0
|
作者：
Emery, P
Fleischmann, RM
Filipowicz-Sosnowska, A
Schechtman, J
Ramos-Remus, C
Gomez-Reino, JJ
Hessey, EW
Shaw, TM
Li, NF
Agarwal, S
机构：
[1] Univ Leeds, Leeds, W Yorkshire, England
[2] Univ Texas, SW Med Ctr, Dallas, TX USA
[3] Inst Rheumatol, Warsaw, Poland
[4] Sun Valley Arthrit Ctr Ltd, Glendale, AZ USA
[5] Ctr Med Occidente, IMSS, Guanajuato, Mexico
[6] Hosp Univ, Fac Med, Santiago, Spain
[7] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[8] Genentech Inc, So San Francisco, CA USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S709 / S709
页数：1
相关论文
共 50 条
  • [1] A double-blind, dose-ranging, placebo-controlled trial of L-arginine for PAD
    Oka, RK
    Szuba, A
    Giacomini, JC
    Kapoor, O
    Soltani, A
    Bene, G
    Cooke, JP
    [J]. CIRCULATION, 2002, 106 (19) : 741 - 741
  • [2] Treatment of rheumatoid arthritis with cefuroxime axetil: A double-blind, placebo-controlled trial.
    Caperton, E
    Peterson, P
    Gomez, G
    Giguere, G
    Collins, J
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 132 - 132
  • [3] The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial
    Emery, P
    Fleischmann, R
    Filipowicz-Sosnowska, A
    Schechtman, J
    Szczepanski, L
    Kavanaugh, A
    Racewicz, AJ
    Van Vollenhoven, RF
    Li, NF
    Agarwal, S
    Hessey, EW
    Shaw, TM
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1390 - 1400
  • [4] Primary analysis of a double-blind, placebo-controlled, dose-ranging trial of rituximab, an anti-CD20 monoclonal antibody, in patients with rheumatoid arthritis receiving methotrexate (Dancer trial)
    Emery, R
    Filipowicz-Sosnowska, A
    Szczepanski, L
    Racewicz, A
    Schechtman, J
    Fleischmann, RM
    Van Vollenhoven, R
    Li, NF
    Agarwal, S
    Hessey, E
    Shaw, TM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 58 - 58
  • [5] Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study
    Stohl, William
    Merrill, Joan T.
    McKay, James D.
    Lisse, Jeffrey R.
    Zhong, Z. John
    Freimuth, William W.
    Genovese, Mark C.
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (05) : 579 - 589
  • [6] Otilonium bromide in irritable bowel syndrome:A dose-ranging randomized double-blind placebo-controlled trial
    Danuta Chmielewska-Wilkoń
    Giorgio Reggiardo
    Colin Gerard Egan
    [J]. World Journal of Gastroenterology, 2014, (34) : 12283 - 12291
  • [7] Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: A double-blind, placebo-controlled, dose-ranging trial
    Bone, Henry G.
    Kiel, Douglas P.
    Lindsay, Robert S.
    Lewiecki, E. Michael
    Bolognese, Michael A.
    Leary, Elizabeth T.
    Lowe, Wing
    McClung, Michael R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (12): : 4671 - 4677
  • [8] Otilonium bromide in irritable bowel syndrome: A dose-ranging randomized double-blind placebo-controlled trial
    Chmielewska-Wilkon, Danuta
    Reggiardo, Giorgio
    Egan, Colin Gerard
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (34) : 12283 - 12291
  • [9] A dose-ranging study of midazolam for postoperative sedation of patients: A randomized, double-blind, placebo-controlled trial
    Hanaoka, K
    Namiki, A
    Dohi, S
    Koga, Y
    Yuge, O
    Kayanuma, Y
    Hidaka, K
    Kusunoki, T
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (06) : 1256 - 1260
  • [10] XIMOPROFEN IN ANKYLOSING-SPONDYLITIS - A DOUBLE-BLIND PLACEBO-CONTROLLED DOSE-RANGING STUDY
    DOUGADOS, M
    NGUYEN, M
    CAPORAL, R
    LEGEAIS, J
    BOUXINSAUZET, A
    PELLEGRIGUEGNAULT, B
    GOMENI, C
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1994, 23 (05) : 243 - 248
12345